Lineage Cell Therapeutics, Inc. - Common Stock (LCTX)

CUSIP: 53566P109

Q3 2026 13F Holders as of 30 Sep 2026

Holder snapshot 6 signals
Share change
+419,750
SEC-reported price per share
$0.96
Number of holders
35
Value change
+$327,741
Number of buys
17
Number of sells
13
Security identity Names, identifiers, and filing context for this profile. 1 source field
Shares outstanding
248,782,811

Security key

53566P109

Report period

Q3 2026

Institutions

35

Top holders

10

Ownership snapshot

Top reported holders of LCTX - Lineage Cell Therapeutics, Inc. - Common Stock (13F + 13D/G + 3/4/5)

Grouped by holder across the latest SEC ownership disclosures. Start with comparable ownership when available, then verify the linked 13F, 13D/G, or 3/4/5 evidence.

Comparable stake leader
BROADWOOD PARTNERS, L.P.
Disclosed value leader
BROADWOOD PARTNERS, L.P.
Comparable rows
3/15
Latest evidence
01 Jul 2026
13D/G 3/4/5 13F Lead comparable stake: 23% 12 rows are not safely comparable across share classes. 13D/G row: BROADWOOD PARTNERS, L.P. Showing 1-6 of 15 holder rows.

Quick read

BROADWOOD PARTNERS, L.P. leads the comparable SEC ownership view at 23%.

3 of 15 rows have a safely comparable ownership percentage. Use this as a filing-backed starting point, then open the detailed table for source links, reporting role, position value, share count, and filing date.

Open SEC evidence Opens BROADWOOD PARTNERS, L.P.'s linked filing trail.
Comparable ownership Top 3
BROADWOOD PARTNERS, L.P. 23%
BlackRock, Inc. 5.3%
Jorey Chernett 5%

Ownership % is shown only when SEC disclosures are safely comparable across share classes.

Detailed SEC evidence table Showing 1-6 of 15 holder rows
Holder Evidence Ownership % Position 12M Net Δ As of
BROADWOOD PARTNERS, L.P.
13D/G 3/4/5
NEAL C. BRADSHER · Director, 10%+ Owner
23%
Reported 13D/G · 12 Nov 2025
$97,763,723
57,848,357 shares
$0 12 Nov 2025
BlackRock, Inc.
13F 13D/G
Company
5.3%
Reported 13D/G · 30 Jun 2026
$17,274,832
13,186,895 shares
— 30 Jun 2026
Jorey Chernett
13D/G
Chernett Jorey
5%
Reported 13D/G · 22 Sep 2025
$13,848,454
11,445,003 shares
$0 22 Sep 2025
Neal C. Bradsher
3/4/5
Director, 10%+ Owner
—
denominator unverified
$151,250
125,000 shares
— 01 Jul 2026
BROADWOOD CAPITAL INC
13F
Company
13F
—
denominator unverified
$64,924,900
49,560,992 shares
— 30 Jun 2026
VANGUARD CAPITAL MANAGEMENT LLC
13F
Company
13F
—
denominator unverified
$11,861,943
9,054,918 shares
— 30 Jun 2026
How to read this table

Rows are grouped by holder and ranked first by SEC-reported ownership % when it is safely comparable, then by disclosed holdings value. — indicates unavailable or non-comparable values; "mixed-class rows" means the latest filing spans non-comparable classes.

13F holder rows

Institutional holders as of Q3 2026

Investor-level positions for this CUSIP, loaded as an interactive table.

Institutions
35
Shares
8,108,439
Rows available
35
Investor Option Weight % Change % SEC-reported value * Price Shares Share Change Activity Report Period

* SEC-reported price is the security price as of the portfolio date and can indicate the last known price at which the security was still held. The marker flags a reported price that did not pass the local price check.

Compare Q3 2026 vs Q2 2026 Across Filers

Q2 2026 holders
130
Q3 2026 holders
35
Holder diff
-95
Investor Q2 2026 Shares Q3 2026 Shares Share Diff Share Chg % Q2 2026 value Q3 2026 value Value change Value Chg %

Trend: ostatnie 8 kwartałów (+ wybrane okresy porównania).

Quarterly Holders Trend
Quarterly Value Trend
Quarterly Shares Trend
We use cookies and similar technologies to provide certain features, enhance the user experience and, if you allow them, measure engagement and deliver advertising. Analytics and marketing storage stay off until you grant consent. By clicking on "Agree and continue", you declare your consent to the use of the selected optional cookies. Manage preferences to update or revoke optional consent for future visits. For more information, see our Privacy Policy .